Implementation and first report of the Brazilian Kidney Biopsy Registry
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0312410 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Irene L Noronha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nephrology Department of the Brazilian Society of Nephrology, São Paulo, Brazil. Hauptthemen laut MEDLINE: Registries, Kidney, Kidney Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Kidney biopsy registries are valuable tools for guiding clinical practice and developing health policies. In 2021, the Brazilian Society of Nephrology (SBN) created the Brazilian Kidney Biopsy Registry (BKBR). This is the first BKBR report, presenting patient data from 2021.
Methods
BKBR is a web-based platform hosted on the BSN website, which contains patient demographics, clinical data, frequency, and distribution of histologic diagnosis of Brazilian adult native kidney biopsies.
Results
Of the 1012 cases registered in 2021, 954 cases were evaluated after excluding pediatric and kidney transplant cases. Twenty-one centers enrolled patients, with representation from all Brazilian regions. There was a slight predominance of females (52.6%), a mean age of 44.7 ± 16 years, and 13.6% of patients were >65 years old. The main indication for kidney biopsy was renal dysfunction (56%) and nephrotic syndrome (41.4%), respectively. At the time of the biopsy, 47.9% of the patients were hypertensive and 15.2% were diabetic. Although 66.2% of patients had eGFR ≤60ml/min/1.73m 2 upon biopsy, the majority (60.2%) had mild interstitial fibrosis and tubular atrophy. The most frequent diagnosis in the BKBR was glomerular disease (74.8%). Lupus nephritis was the most frequent diagnosis of glomerular disease (22.6%), followed by IgA nephropathy (13%) and focal segmental glomerulosclerosis (12.2%).
Conclusion
This is the first report of a Nationwide registry of kidney biopsies in Brazil. This data provides pivotal information about the kidney disease profile in this country with continental dimensions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Nephrology Department of the Brazilian Society of Nephrology, São Paulo, Brazil.
- Renal Division, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
- Division of Nephrology, Sao Jose do Rio Preto Medical School, Sao Paulo, Brazil.
- Renal Division, Hospital Universitário Walter Cantídio, Fortaleza, Brazil.
- Postgraduate, Radiology Institute Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
- Nephrology Discipline, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, Brazil.
ORCID-Profile: Osvaldo Merege Vieira-Neto, Precil Diego Miranda de Menezes Neves
Zitieren
APA
Noronha, I. L., Ramalho, R. J., Oliveira, C. M. C., Bahiense-Oliveira, M., Barbosa, F. A. M., Barros Neto, J. R., Mitsuoka, R., Vieira-Neto, O. M., Neves, P. D. M. M., & Brazilian Kidney Biopsy Registry Working Group (2025). Implementation and first report of the Brazilian Kidney Biopsy Registry. PLOS ONE. https://doi.org/10.1371/journal.pone.0312410
Vancouver
Noronha IL, Ramalho RJ, Oliveira CMC, Bahiense-Oliveira M, Barbosa FAM, Barros Neto JR, et al. Implementation and first report of the Brazilian Kidney Biopsy Registry. PLOS ONE. 2025. doi:10.1371/journal.pone.0312410
BibTeX
@article{Noronha2025,
author = {Noronha, Irene L and Ramalho, Rodrigo José and Oliveira, Claudia Maria Costa de and Bahiense-Oliveira, Marilia and Barbosa, Fabricio Augusto Marques and Barros Neto, Jose de Resende and Mitsuoka, Ronny and Vieira-Neto, Osvaldo Merege and Neves, Precil Diego Miranda de Menezes and Brazilian Kidney Biopsy Registry Working Group, Brazilian Kidney Biopsy Registry Working Group},
title = {Implementation and first report of the Brazilian Kidney Biopsy Registry},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0312410}
}
EUVIMED